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Assessing the genetic contribution of Neanderthals to non-disease phenotypes in modern humans has been difficult because of the
absence of large cohorts for which common phenotype information is available. Using baseline phenotypes collected for 112,000
individuals by the UK Biobank, we can now elaborate on previous findings that identified associations between signatures of positive
selection on Neanderthal DNA and various modern human traits but not any specific phenotypic consequences. Here, we show that
Neanderthal DNA affects skin tone and hair color, height, sleeping patterns, mood, and smoking status in present-day Europeans. Inter-
estingly, multiple Neanderthal alleles at different loci contribute to skin and hair color in present-day Europeans, and these Neanderthal
alleles contribute to both lighter and darker skin tones and hair color, suggesting that Neanderthals themselves were most likely variable
in these traits.Introduction
Interbreeding between Neanderthals and earlymodern hu-
mans has been shown to have contributed about 2%Nean-
derthal DNA to the genomes of present-day non-Africans.
This Neanderthal DNA has apparently had both positive
and negative effects. Together with the rapid decrease in
Neanderthal ancestry after introgression, the depletion of
Neanderthal DNA around functional genomic elements
in present-day human genomes suggests that a large
fraction of Neanderthal alleles are deleterious in modern
humans.1–4 However, recent studies have also identified
a number of introgressed Neanderthal alleles that have
increased in frequency in modern humans and that
might contribute to genetic adaptation to new environ-
ments. Adaptive variants in genes related to immunity,
skin and hair pigmentation, and metabolism have been
identified.4–11
The majority of Neanderthal alleles in the genomes of
people today are, however, not strongly adaptive and are
therefore present at low frequencies (<2%) in present-
day populations. To date, the number of individuals for
whom genotype and phenotype information is available
has been limited, making it difficult to study archaic alleles
that are at such low frequencies or to link them to pheno-
typic variation. A recent study used the electronic medical
records and genotypes of 28,000 individuals to address the
contribution of these less frequent Neanderthal alleles to
clinical traits in modern humans. It showed that a large
number of Neanderthal variants at different loci influence
risk of a number of disease traits, including depression,
skin lesions, and blood-clotting disorders, and that Nean-
derthals contributed both risk and protective alleles for
these traits.12 However, evaluating the broader contribu-
tion of Neanderthals to common phenotypic variation in
modern humans, or inferring Neanderthal phenotypes,
has not been possible largely because of the limited num-1Department of Evolutionary Genetics, Max Planck Institute for Evolutionary
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common phenotype information.
In addition to collecting genotype data via a custom
genotyping array, the UK Biobank has collected baseline
phenotypes, including traits related to physical app-
earance, diet, sun exposure, and behavior, as well as dis-
ease, for more than 500,000 people.13 The pilot dataset
including genotypes and phenotypes for more than
150,000 of the individuals was recently made available
for study. Using these data, we studied the contribution
of Neanderthals to common human phenotypic variation
in 112,338 individuals from the UK Biobank to determine
the set of traits to which Neanderthals have contributed
and to evaluate the relative contribution of archaic and
non-archaic alleles to common phenotypic variation in
modern humans.Material and Methods
Datasets from the UK Biobank
We obtained genotype and phenotype data from the pilot phase
of the UK Biobank project.13 Genotyping was performed with
two arrays (UK BiLEVE and UK Biobank Axiom) that share 95%
of markers, resulting in a merged dataset with genotype informa-
tion for 152,729 individuals across 822,111 genomic sites.Filtering Genotype Data
UK Biobank quality control (QC) included tests for batch, array,
plate, and sex effects, as well as departures from Hardy-Weinberg
equilibrium and discordance across control replicates. We used in-
formation provided by the UK Biobank to remove a total of 40,391
individuals; of these, 480 were related according to a kinship infer-
ence analysis, 17,308 had significantly decreased heterozygosity
levels, and 32,443 had substantial non-European ancestry accord-
ing to self-reported information and a principle-component anal-
ysis of the SNP data. Extensive documentation of the QC for these
data is available on the UK Biobank’s website.Anthropology, Leipzig 04103, Germany
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icense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Annotating Non-archaic and Archaic-like SNPs
A total of 825,927 polymorphic sites were genotyped. We took a
two-step approach to annotate SNPs on the basis of whether
they carried an allele of putative archaic origin. First, we identified
potentially introgressed alleles by selecting SNPs that had one
fixed allele in Yoruba individuals, an African population with
little to no inferred Neanderthal DNA (1000 Genomes Project14
phase 3), and a different allele in a heterozygous or homozygous
state in the genome of the Altai Neanderthal15 and that segregated
in any of the UK Biobank individuals (we refer to these variants as
archaic-like SNPs [aSNPs]). We then expanded this by requiring
that the identified aSNPs overlap confidently inferred tracts of
Neanderthal introgression in modern humans4 that have a Nean-
derthal posterior probability greater than 0.9 and a length of at
least 0.02 cM. In the construction of this introgression map, a
number of criteria were used to ensure that the identified haplo-
types were highly likely to be of introgressed origin: (1) alleles
were required to be shared between non-Africans and Neander-
thals but not be present in sub-Saharan Africans, (2) haplotype
lengths had to be consistent with admixture 50,000 years ago,
and (3) haplotypes had to have a lower divergence to a Neander-
thal reference genome than to African genomes.
We then collapsed sets of SNPs that were in high linkage disequi-
librium (LD) into one representative tag SNP. To do so, we used
PLINK16 (parameters: –ld-window-r2 0.8 –ld-window 99999) and
computed LD between all SNPs among the 152,729 individuals
by combining sets of SNPs with r2 > 0.8 into clusters. For clusters
with at least one aSNP, we selected a random aSNP as the tag
SNP. In clusters without aSNPs, we chose a random tag SNP.
Non-archaic SNPs and aSNPs with no other SNPs in high LD
were defined to be their own tag SNP. We identified a total of
534,341 tag SNPs, of which 6,671 were of putative archaic origin
and 527,670 were of non-archaic origin.
To ensure a robust correlation between genotypes and pheno-
types, we required each tag SNP to have a reasonable representa-
tion of both alleles. We therefore kept all tag SNPs where at least
100 individuals were heterozygous and at least 20 were homozy-
gous for the minor allele, resulting in 6,210 archaic-like tag SNPs
and 439,749 non-archaic tag SNPs.Phenotype Data
Baseline phenotype data were available for different subsets of
individuals (Table S1). Of these phenotypes, we used the 136
(including diet, cognitive functions, physical measurements, and
self-reported medical conditions) for which data were available
for at least 80,000 individuals (Table S1). We excluded phenotypes
with complex measurements (e.g., electrocardiography). Pheno-
types were represented either in categorical form (72 phenotypes)
or as continuous variables (64 phenotypes) (Table S1).Correlation of Genotype and Phenotype Data
Linear or logistic regression is typically used in association
testing to account for potentially confounding covariates such
as sex, age, and ancestry; however, applying this standard
approach to the UK Biobank is challenging because some of
the phenotypes are represented in categorical form for two or
more categories, whereas other phenotypes are continuous.
Linear regression or generalized linear models are widely used
for continuous variables and require knowledge of the distribu-
tion of data to be modeled. This distribution is likely to differ
between phenotypes, and its assessment is not always trivial.The AmericaLogistic regression is typically applied to binary phenotypes,
such as disease phenotypes. However, many of the categorical
phenotypes in the UK Biobank have more than two categories
and therefore cannot be transformed into binary data. Another
option is to use a multinomial logistic regression, which would
require testing each of the categories independently and would
vastly increase the complexity of the analysis. We therefore
used the chi-square test (for categorical data) and Spearman’s cor-
relation (for continuous data) because these statistics make fewer
assumptions and are directly applicable to the two classes of
phenotypes (categorical and continuous) in the UK Biobank.
We excluded categorical data categories for which fewer than
1,000 individuals were available. However, neither test accounts
for covariates such as ancestry, age, and sex. There is a strong cor-
relation between ancestry and the presence of Neanderthal al-
leles. We therefore carefully selected individuals with very little
variation in ancestry. There is no a priori reason to assume any
correlation between Neanderthal ancestry and factors such as
age and sex (and no previous study has shown such a correla-
tion). We explicitly tested the impact of these factors on our re-
sults by (1) comparing results of linear models with and without
covariates and (2) showing that these results were consistent
with the results we obtained with a chi-square test (Table S2).
To do so, we selected all 21 binary phenotypes and computed
an association with all aSNPs by using (1) a chi-square test, (2)
a logistic regression without any other covariates, (3) a logistic
regression with age and sex as covariates, and (4) a logistic regres-
sion with age and sex as covariates and all interactions between
age, sex, and genotype.
We found that the correlation between association p values with
archaic alleles was between rho ¼ 0.99999 and rho ¼ 1 (Spear-
man’s correlation) for the comparisons of (2) and (3) and of (2)
and (4), suggesting that including age and sex has only a marginal
impact on the estimation of the association p value.
To estimate the similarity between the results of a logistic regres-
sion without covariates (2) and those of a chi-square test (1), we
also correlated association p values between the binary pheno-
types and archaic alleles for (1) and (2) and found that they ranged
between rho ¼ 0.65 and rho ¼ 0.67 (Spearman’s correlation; all
p << 1.0 3 1016), suggesting that both tests show highly similar
results.
Additionally, we correlated genotypes for all aSNPs used in
this study with age and sex and found that there was no signif-
icant correlation between these two factors and the aSNP geno-
types (false-discovery rate [FDR] < 0.05, min FDRsex ¼ 0.33, min
FDRage ¼ 0.28).
These results suggest that age and sex have very little impact on
our calculation of the phenotype association for binary pheno-
types, and we infer that non-binary phenotypes are also not likely
to be affected by these factors. Applying more sophisticated
methods to the analysis of specific phenotypes could increase
power to detect additional associations.
For both tests, we considered associations that reached p< 1.03
108 as significant. This addresses the multiple-testing problem
encountered when the associations between 136 phenotypes
and approximately 6,000 aSNPs are evaluated (family-wise error
rate ¼ 1.0 3 108 3 6,000 3 136 ¼ 0.01).Phenotypic Impact of Archaic and Non-archaic Alleles
For all tag aSNPs, we computed an association p value between
genotype and phenotype for each phenotype. We then clusteredn Journal of Human Genetics 101, 578–589, October 5, 2017 579
tag aSNPs into archaic allele-frequency bins of size 1% and selected
frequency-matched non-archaic tag SNPs by matching the num-
ber of non-archaic alleles from each frequency bin to the number
of archaic alleles. For each phenotype, we created 1,000 random
frequency-matched non-archaic sets and computed for each tag
SNP an association p value for the phenotype.
To determine whether the archaic p value distributions were
shifted to lower or higher significant p values than the non-archaic
distributions, we determined the distances between the sets of
archaic and non-archaic distributions. More specifically, for each
phenotype, we computed empirical p values for the component
aSNPs with associations p< 1.03 104 and compared their cumu-
lative density distribution with the 1,000 non-archaic cumulative
density p value distributions (Table S3). We selected the aSNP at
which the distance between the archaic distribution and the
non-archaic distribution was largest. We corrected all p values
for each phenotype for multiple testing by using the Benjamini-
Hochberg approach.
Candidate-Gene Analysis and Molecular Mechanism
Given that archaic alleles are typically present on longer haplotypes
that we cannot determine directly from the UK Biobank array data,
weused the1000Genomes14 (phase3) individuals to identify aSNPs
that were not directly genotyped in the UK Biobank. We computed
LDbetween these by using PLINK (see AnnotatingNon-archaic and
Archaic-like SNPs) andcombinedsetsofaSNPswith r2>0.8between
all pairs into a haplotype. We defined the borders of the inferred
archaic-like haplotype to be the most distant two aSNPs (Table 1).
We then assigned all 13 candidate tag aSNPs with an association
p value < 1.03 108 (Table 1) to archaic haplotypes inferred from
1000 Genomes.
To determine the targets of these significantly associated aSNPs,
we identified overlapping protein-coding genes (Ensembl version
GRCh37) or assigned the haplotype to the nearest gene if there
was no direct overlap. For each archaic-like haplotype, we identi-
fied protein sequence and regulatory variants among the aSNPs
in each haplotype and computed the predicted effect of the amino
acid changes by using the VEP.17 Two of the haplotypes with
significantly associated aSNPs carried an archaic missense allele
(Table 1). To determine whether significantly associated aSNPs
might modify gene regulation, we used a previously published
set of associations between archaic haplotypes and differential
expression in 48 human tissues from the Genotype-Tissue Expres-
sion (GTEx) dataset.18 Of the haplotypes with significantly associ-
ated aSNPs, eight were also associated with the expression change
of a nearby gene (within 50 kb) in at least one tissue (Table 1).
Testing whether Inferred Archaic Haplotypes Exceed the
Length Expected by Incomplete Lineage Sorting
We tested whether the lengths of archaic haplotypes exceeded the
length of segments resulting from incomplete lineage sorting (ILS)
by using a conservative age of the Altai Neanderthal according to a
mutation rate of 1.0 3 109 per base pair per year and applying
the approach presented by Huerta-Sa´nchez et al.19 and the average
recombination rates20 at the inferred haplotype. We corrected the
p values obtained from that approach for multiple testing by using
the Benjamini-Hochberg method and added them to Table 1.
Haplotype Trees for Candidate Loci
For each of the 13 inferred archaic haplotypes with significant
phenotype associations, we extracted the genomic sequences of580 The American Journal of Human Genetics 101, 578–589, Octobeall 1000 Genomes phase 3 individuals, as well as the genome
sequences of the Altai Neanderthal, Denisovan, and chimpanzee
(pantro4) (Table 1). We removed non-variable sites and sites where
either of the archaic individuals was polymorphic. We then clus-
tered the haplotypes of the combined set of modern and ancient
humans together with the chimpanzee into core haplotypes by
combining haplotypes that differed by fewer than1/1,000 bases.
Rooted neighbor-joining trees based on the consensus sequences
of the resulting core haplotypes and with chimpanzee as an
outgroup were computed and are displayed in Figure S1.Results
We analyzed 136 baseline phenotypes in 112,338 individ-
uals of British ancestry from the UK Biobank pilot study.
A total of 822,111 SNPs directly genotyped in this cohort
were classified as either ‘‘archaic’’ or ‘‘non-archaic’’ on the
basis of their inclusion in a previously published map
of Neanderthal ancestry4 and their similarity to the Altai
Neanderthal genome15 (Material and Methods). We note
that LD between Neanderthal introgressed alleles tends
to be higher than LD between non-introgressed alleles
because of the timing of Neanderthal introgression. To
ensure that the phenotype associations with archaic
and non-archaic haplotypes were unbiased, we selected
a random tag SNP for each set of SNPs in high LD
(r2 > 0.8) and labeled these as ‘‘archaic’’ if the LD set con-
tained at least one ancient SNP and as ‘‘non-archaic’’ other-
wise. To ensure sufficient power to detect the phenotypic
contribution of each allele, we filtered all tag SNPs for a
minimum minor allele frequency (Material and Methods),
resulting in a final set of 6,210 archaic tag SNPs and
439,749 non-archaic tag SNPs. We then retained only
variants on archaic haplotypes that exceeded the length
expected by ILS (Material and Methods).
Phenotypes in the UK Biobank are represented either
as categorical (72 phenotypes) or continuous (64 pheno-
types) data (Table S1). Linear or logistic regression is typi-
cally used in association testing to account for potentially
confounding covariates such as sex, age, and ancestry. To
avoid testing each of the categories independently, which
vastly increases the complexity of the analysis, we applied
two different tests: for continuous data, we applied Spear-
man’s correlation to test for an association between each
tag SNP and the phenotypic measurement, whereas for
categorical data, we used a chi-square test to test for associ-
ations between tag SNPs and phenotypes (Material and
Methods) and considered only associations that reached
p < 1.0 3 108 as significant. By comparing our results
to those of linear models for subsets of the data, we found
that covariates such as age and sex had very little impact
on our calculations of phenotype association (Material
and Methods and Table S2).
For 11 phenotypes, a total of 15 associations reached
genome-wide significance (p < 1.0 3 108; Tables 1 and
S4). Among these 15 associations were Neanderthal alleles
that increase both sitting height and height attained at ager 5, 2017



























– FANCA: muscle (skeletal), lung,
pancreas, esophagus (muscularis),
adipose (subcutaneous), nerve
(tibial), artery (tibial), whole blood
1.84 3 109
SPIRE2: muscle (skeletal), heart
(atrial appendage), adipose (visceral;
omentum); skin (not sun exposed;
suprapubic), minor salivary gland,
esophagus (muscularis), esophagus
(mucosa), esophagus (gastresophageal
junction), testis, skin (sun exposed;
lower leg), adipose (subcutaneous),
nerve (tibial), artery (tibial), heart
(left ventricle), cells (transformed
fibroblasts), artery (aorta), pituitary
TCF25: uterus, brain (putamen;
basal ganglia)
TUBB3: vagina, esophagus (mucosa)
MC1R: breast (mammary tissue)
DBNDD1: breast (mammary tissue),
skin (not sun exposed; suprapubic),
skin (sun exposed; lower leg),
whole blood
GAS8-AS1 (MIM: 605179): testis
DEF8: skin (sun exposed; lower leg)






4.21 3 1030 0.075 categorical chr6: 45,533,261–
45,680,205








1.59 3 1022 0.77 categorical chr9: 16,720,122–
16,804,167







4.56 3 1021 0.089 categorical chr14: 92,767,097–
92,801,297





1.6 3 1014 0.19 categorical chr9: 16,891,561–
16,915,874
BNC2* – – 0.001



































































Mutations Associated eQTLs FDR ILS Test
Comparative height





3.97 3 1014 0.16 categorical chr19: 30,982,165–
31,041,053


























5.54 3 1010 0.041 categorical chr11: 89,996,325–
90,041,511















NMB (MIM: 162340): muscle (skeletal),
minor salivary gland, adrenal gland,
pancreas, esophagus (muscularis),
esophagus (mucosa), stomach,
small intestine (terminal ileum),
colon (transverse), testis, skin




WDR73 (MIM: 616144): heart
(atrial appendage), brain (cortex),
thyroid, esophagus (muscularis),
nerve (tibial), ovary, brain (anterior
cingulate cortex; BA24)
SLC28A1 (MIM: 606207): breast
(mammary tissue)




SEC11A: brain (anterior cingulate
cortex; BA24)









1.49 3 109 0.77 continuous chr9: 16,720,122–
16,804,167
BNC2 – BNC2: muscle (skeletal) 1.62 3 1012












































































– PBLD: muscle (skeletal), brain (cortex),
brain (caudate; basal ganglia), brain
(putamen; basal ganglia)
0.002
ATOH7 (MIM: 609875): artery
(coronary), breast (mammary tissue),
skin (not sun exposed; suprapubic),
minor salivary gland, adrenal gland,
pancreas, esophagus (gastresophageal
junction), colon (transverse), adipose
(subcutaneous), artery (tibial), brain
(cerebellum), artery (aorta), spleen








2.91 3 109 0.07 categorical chr6: 503,851–
544,833





4.09 3 109 0.017 categorical chr10: 94,574,048–
94,756,023














NMB: muscle (skeletal), minor salivary
gland, adrenal gland, pancreas,
esophagus (muscularis), esophagus
(mucosa), stomach, small intestine
(terminal ileum), colon (transverse),
testis, skin (sun exposed; lower leg),
artery (tibial), cells (transformed
fibroblasts), spleen, liver
1.17 3 105
WDR73: heart (atrial appendage),
brain (cortex), thyroid, esophagus
(muscularis), nerve (tibial), ovary,
brain (anterior cingulate cortex; BA24)
SLC28A1: breast (mammary tissue)
ZNF592: lung, pancreas, liver
GOLGA6L4: small intestine
(terminal ileum)
SEC11A: brain (anterior cingulate
cortex; BA24)
ALPK3: brain (cerebellar hemisphere)
ADAMTSL3: brain (amygdala)
This table shows archaic alleles with genome-wide-significant associations (column 4, p < 1.0 3 108) and their corresponding phenotype (column 1) and meta-phenotype (column 2). Only archaic alleles on confidently
inferred archaic introgressed haplotypes are included. The archaic allele frequency in the UK Biobank cohort is given in column 5. Gene identifiers for overlapping or nearest genes (marked with an asterisk) are in column 8.
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Figure 1. Archaic Haplotypes Associated with Skin and Hair Phenotypes
(A–D) Neanderthal allele frequency in percentage (x axis) and the number of individuals in the UK Biobank cohort for four aSNPs that
show strong associations with skin and hair phenotypes (y axis): chr9: 16,904,635 (rs62543578) associated with skin color (A),
chr9: 16,804,167 (rs10962612) associated with ease of skin tanning (B) and incidence of childhood sunburn (C) (illustrated are the
average numbers of childhood sunburns for individuals with the three genotypes), and chr16: 89,947,203 (rs62052168) associated
with hair color (D).
(E and F) The genomic locations of introgressed haplotypes for the aSNPs showing significant associations in (A)–(D). Gray vertical lines
denote the extent of the inferred archaic haplotypes on chromosomes 9 (E) and 16 (F). At the top, we show all aSNPs that are within the
inferred archaic haplotypes and are present in any 1000 Genomes individual. The associated tag SNPs directly genotyped by the UK
Biobank are marked in red, and other aSNPs within the archaic haplotypes and genotyped in the UK Biobank are marked in orange.
The associated tag aSNPs represented in (A)–(D) are marked on the x axis.10 years, alleles that reduce measures of leg impedance
(suggesting reduced body fat composition), and alleles
that increase resting pulse rate (Table 1). Strikingly, more
than half of the significantly associated alleles that we
identified are related to skin and hair traits, consistent
with previous evidence that genes associated with skin
and hair biology are over-represented in introgressed
archaic regions.4,9,11 It was previously only possible to
speculate about the precise effect of the introgressed alleles
on skin and hair phenotypes on the basis of the genes that
were in or near the introgressed haplotypes. We can now
directly determine the effect of Neanderthal alleles on
these traits in modern humans by correlating Neanderthal
ancestry with phenotypes of individuals in the UK Bio-
bank cohort.
The strongest association we found in this study was an
archaic allele under-represented among red-haired indi-
viduals. This archaic allele is on an introgressed haplotype584 The American Journal of Human Genetics 101, 578–589, Octobecomposed of 71 aSNPs and encompassing five genes:
FANCA (MIM: 607139), SPIRE2 (MIM: 609217), TCF25
(MIM: 612326), MC1R (MIM: 155555), and TUBB3 (MIM:
602661) (rs62052168, p ¼ 3.7 3 10202; Figure 1 and
Table 1). MC1R is a key genetic determinant of pigmenta-
tion and hair color and is therefore a good candidate for
this association. More than 20 variants in MC1R have
been shown to alter hair color in humans.21–28 None of
the variants resulting in red hair in modern humans are
present in either of the two high-coverage Neanderthal
genomes that have been sequenced (Table S5). Therefore,
Neanderthals appear not to carry any of the variants
associated with red hair in modern humans. Further, a
Neanderthal-specific variant (p.Arg307Gly) postulated
to reduce the activity of MC1R and result in red hair
was identified by PCR amplification of MC1R in two
Neanderthals.29 However, this putative Neanderthal-
specific variant is also not present in the Neanderthalsr 5, 2017
genomes that have been sequenced to date, suggesting
that if this variant was present in Neanderthals, it was
rare. Using the high-coverage Neanderthal genomes,
we identified only one additional Neanderthal-specific
MC1R amino acid change for which the effect on hair co-
lor is unknown. However, it is polymorphic among Nean-
derthals, indicating that any phenotype that it confers was
variable in Neanderthals (Table S5). Finally, because the in-
trogressed haplotype we identified in this cohort is under-
represented among red-haired individuals, we conclude
that if variants contributing to red hair were present in
Neanderthals, they were probably not at high frequency.
We also identified strongly associated archaic alleles on
two unlinked introgressed haplotypes near BNC2 (MIM:
608669), a gene that has been previously associated with
skin pigmentation in Europeans.30 The first archaic haplo-
type (chr9: 16,720,122–16,804,167) is tagged by an archaic
allele (rs10962612) that has a frequency of more than 66%
in European populations (Table S6 and Figure 1) and is
associated with increased incidence of childhood sunburn
(p ¼ 1.53 109) and poor tanning (p¼ 1.63 1022) in the
UK Biobank cohort (Table 1). A Neanderthal haplotype in
this region was previously identified by Vernot and
Akey,11 and the association with sun sensitivity is consis-
tent with the previous finding that Neanderthal alleles
on this haplotype result in an increased risk of kera-
tosis.12 All of the Neanderthal-like SNPs overlapping
BNC2 on this haplotype have significant scores in a test
for recent positive selection in Europeans31 (singleton den-
sity score > 3), perhaps indicating their importance in
recent local adaptation.
Interestingly, a second, less-frequent (19%) archaic
haplotype near BNC2 (chr9: 16,891,561–16,915,874;
rs62543578; Table S6) shows strong associations with
darker skin pigmentation in individuals with British
ancestry in theUKBiobankcohort (p¼1.631014; Figure1
and Table 1). These results suggest that multiple alleles in
andnearBNC2, some ofwhich are contributed byNeander-
thals, have different effects onpigmentation inmodernhu-
mans. Our analysis identified six additional associations
(p < 1.0 3 108) contributing to variation in skin and hair
biology at other introgressed loci (Table 1). Individuals
with blonde hair show a higher frequency of the Nean-
derthal haplotype at chr6: 503,851–544,833 (overlapping
EXOC2 [MIM: 615329]), whereas individuals with darker
hair color show higher Neanderthal ancestry at chr14:
92,767,097–92,801,297 (overlapping SLC24A4 [MIM:
609840]). Two further archaic haplotypes on chromosomes
6 (chr6: 45,533,261–45,680,205, overlapping RUNX2
[MIM: 600211]) and 11 (chr11: 89,996,325–90,041,511;
nearest gene: CHORDC1 [MIM: 604353]) are both signifi-
cantly associated with lighter skin color (Table 1). The
apparent variation in thephenotypic effects ofNeanderthal
alleles in this cohort demonstrates that it is difficult to confi-
dently predict Neanderthal skin and hair color.
Additionally, it is not clear that phenotypic inference
from single variants for which a function is known onThe Americathemodern human genetic background provides sufficient
evidence for extrapolating effects in Neanderthals, espe-
cially given the challenges with predicting complex phe-
notypes in present-day humans on the basis of genomic
data.32
In addition to the introgressed haplotypes contributing
to skin and hair traits, we also found two archaic haplo-
types that contribute significantly to differences in sleep
patterns (Table 1). One of the introgressed SNPs modifies
the coding sequence of ASB1 (MIM: 605758; rs3191996,
p.Ser37Lys; Material and Methods). Archaic alleles near
ASB1 (tag aSNP: rs75804782; Figure 2 and Table 1) and
EXOC6 (MIM: 609672; tag aSNP rs71550011; Table 1) are
associated with a preference for being an ‘‘evening person’’
and an increased tendency for daytime napping and narco-
lepsy, respectively. Humans show wide variation in diurnal
preferences and can be divided into ‘‘chronotypes,’’ which
have been shown to have a genetic component.33 Two pre-
vious studies of chronotypes identified strongly associated
SNPs in the ASB1 region.34,35 Of the 540 SNPs with signif-
icant genome-wide associations in Hu et al.34 (p < 1.0 3
108), ten overlapped the region identified near ASB1,
and four of these were labeled as introgressed archaic
variants. Lane et al. identified two ASB1-adjacent SNPs
that showed significant associations with chronotype.35
Neither of these are of archaic origin, but they are in
high LD with aSNPs on the associated haplotype
(maximum r2 ¼ 0.73, based on Europeans in 1000
Genomes phase 3), suggesting that these are not indepen-
dent signals. Given the association scores calculated by
Hu et al.,34 the association is stronger for the set of aSNPs
(p values ranging from 3.4 3 106 to 2.6 3 109;
rs75804782 has the second-most-significant association
at p ¼ 4.4 3 109) than for the non-archaic SNPs reported
by Lane et al.35 (rs3769118, p ¼ 1. 9 3 106; rs11895698,
p ¼ 3.2 3 106), suggesting that the association is likely
to be driven by the introgressed archaic haplotype. Because
the natural length of day-night cycles differs according to
latitude and influences circadian rhythms, we tested for a
correlation between the Neanderthal allele frequency at
ASB1 and latitude in worldwide non-African popula-
tions.36We found a significant correlation between the fre-
quency of the Neanderthal allele near ASB1 (rs75804782)
and latitude (Spearman’s rho ¼ 0.21, p ¼ 0.03). The fact
that populations further from the equator have higher fre-
quencies of the Neanderthal allele at ASB1 than popula-
tions nearer the equator (Figure 2B) is consistent with the
influence of daylight exposure on circadian rhythm,37
although the functional link between these genes and
chronotype traits is unclear.
Given the large number of associations with skin and
hair traits, it is tempting to speculate that Neanderthals
might have had an outsized contribution to these pheno-
types. However, the number of significant associations
that can be identified for a trait is dependent on how poly-
genic the traits are and how they are measured. Power to
measure the contribution of an allele depends also onn Journal of Human Genetics 101, 578–589, October 5, 2017 585



















































Figure 2. Archaic Haplotype Associated with Chronotype
(A) The Neanderthal allele frequency in percentage (x axis) and the number of individuals in the UK Biobank cohort for the four reported
chronotype phenotypes (y axis; from top to bottom: definitely an evening person, more an evening than a morning person, more a
morning than an evening person, definitely a morning person) for the archaic tag SNP with the strongest association with chronotype
(position chr2: 239,316,043 [rs75804782] near ASB1).
(B) Worldwide frequency of the archaic allele (C, blue) and the modern human allele (T, orange) in the Simons Genome Diversity Panel
populations.
(C) The association p values (y axis; in the form of log10(p)) with chronotype for all archaic and non-archaic SNPs (squares) genotyped
by the UK Biobank study in the region of the inferred archaic haplotype at chr2: 239,316,043–239,470,654. The tag SNP at chr2:
239,316,043 (rs75804782) is shown in red, other aSNPs are shown in orange, and non-archaic SNPs are shown in black. The
genome-wide significance cutoff of p¼ 1.03 108 and the extent of the inferred archaic haplotype are illustratedwith dashed horizontal
and vertical gray lines, respectively. At the top, we show all aSNPs that are within the inferred archaic haplotype and are present in any
1000 Genomes individual. The directly genotyped SNPs from the UK Biobank are illustrated as red (the archaic tag SNP) and orange bars.
One archaic allele that leads to a missense mutation in ASB1 is marked as a green bar.
(D) The cumulative density distribution of p values (zoom in for p < 0.01, x axis log scale) for associations between archaic alleles and
chronotype (red line) and the 95% confidence interval region for 1,000 cumulative density distributions of associations between non-
archaic alleles matched to the Neanderthal allele frequency and chronotype (gray shading).the minor allele frequency. In the case of archaic alleles,
which are generally less frequent (1%–5%), this is of
particular relevance. We therefore tested whether the
impact of archaic alleles on particular traits is more or
less than that of non-archaic alleles by comparing the con-
tributions of archaic alleles with the contributions of 1,000
similarly sized sets of frequency-matched non-archaic tag
SNPs. Phenotypes with an enrichment of low association
p values for archaic alleles could indicate a larger-than-ex-
pected contribution of introgressed archaic DNA to these
phenotypes, whereas an enrichment of low p values for
non-archaic alleles suggests a lower contribution from
archaic alleles to the phenotype. We note that our fre-
quency matching of archaic and non-archaic alleles does
not account for multiple other factors that might differ be-
tween these two sets of variants. For example, the longer
haplotypes associated with archaic introgression mean586 The American Journal of Human Genetics 101, 578–589, Octobethat archaic variants might be more likely to occur
together. However, it is unclear whether the higher num-
ber of archaic alleles on archaic haplotypes would increase
or decrease the chance of being significantly associated
with phenotypes in modern humans. We believe that
further matching of, for example, haplotype length or
number of SNPs of a haplotype introduces new potential
biases and does not solve this problem. For each pheno-
type, we selected the lower tail of the p value distributions
(p < 1.0 3 104) for archaic and non-archaic SNPs and
then tested whether the archaic p value distribution was
significantly different from 1,000 non-archaic distribu-
tions (Material and Methods). For the majority of pheno-
types (130/136), we found no difference between the
relative contribution of archaic alleles and that of non-
archaic alleles, indicating that for most phenotypes
measured here, Neanderthal alleles contribute phenotypicr 5, 2017
variation proportionally to non-archaic SNPs at similar fre-
quencies (Table S3). We detected six phenotypes where
there was a significant difference between the p values dis-
tributions for archaic alleles and those for non-archaic al-
leles (FDR < 0.05). Neanderthal alleles contributed more
variation in four behavioral phenotypes influencing sleep,
mood, and smoking behaviors, suggesting that Neander-
thal alleles contribute more to these traits than expected
from their frequency in modern humans. Conversely, for
two associations (ease of skin tanning and pork intake),
non-archaic alleles showed lower association p values
(Table S3), indicating that introgressed Neanderthal alleles
contribute less than frequency-matched non-archaic al-
leles to these traits.Discussion
Largely on the basis of disease cohorts and signatures of
positive selection, a number of immune, skin, metabolic,
and behavioral phenotypes have been suggested to be
influenced by archaic ancestry. Using the UK Biobank
cohort, we have now been able to test the contribution
of introgressed Neanderthal alleles to 136 common,
largely non-disease phenotypes in present-day Europeans.
We found that skin and hair traits are over-represented
among the most significant associations with archaic
alleles. However, when we compared the contribution of
alleles of Neanderthal origin with the contributions of al-
leles of modern human origin, we found that both archaic
and non-archaic variants contribute equally to skin and
hair phenotypes, consistent with a neutral contribution
from Neanderthals and with the idea that Neanderthals
themselves were likely to be variable with respect to these
traits. In fact, for most associations, Neanderthal variants
do not seem to contribute more than non-archaic variants.
However, there are four phenotypes, all behavioral, to
which Neanderthal alleles contribute more phenotypic
variation than non-archaic alleles: chronotype, loneliness
or isolation, frequency of unenthusiasm or disinterest in
the last 2 weeks, and smoking status. Of these, the signif-
icant association between a Neanderthal variant in ASB1
and preference for evening activity also shows a corre-
lation between the Neanderthal allele frequency and
latitude, suggesting a link to differences in sunlight
exposure for this phenotype. Additionally, the phenotype
of increased frequencies of unenthusiasm or disinterest in
the last 2 weeks was significantly associated with an
archaic haplotype (chr5: 29,936,068–29,974,930; nearest
gene: CDH6 [MIM: 603007]), and Neanderthal alleles
also contributed more often to this phenotype than non-
archaic alleles. A number of the associations we detected,
such as dermatological traits, smoking, and mood disor-
ders, overlap associations found in previous studies.4,11,12
Some of the psychiatric and metabolic phenotypes, such
as obesity, identified in Simonti et al.12 were not replicated
in our study. We speculate that this might partially reflectThe Americadifferences in the criteria for cohort selection; individuals
in the eMERGE cohort are already undergoing medical
treatment, whereas volunteers for the UK Biobank cohort
are not.
Multiple phenotypes significantly influenced by Nean-
derthal introgression have some link to sunlight exposure.
Given that Neanderthals had inhabited Eurasia for more
than 200,000 years, they were most likely adapted to lower
UVB levels and wider variation in sunlight duration than
the early modern humans who arrived in Eurasia from
Africa around 100,000 years ago.38 Skin and hair color,
circadian rhythms, and mood are all influenced by light
exposure. We speculate that their identification in our
analysis suggests that sun exposure might have shaped
Neanderthal phenotypes and that gene flow into modern
humans continues to contribute to variation in these traits
today.Supplemental Data
Supplemental Data include one figure and six tables and can be
found with this article online at https://doi.org/10.1016/j.ajhg.
2017.09.010.Acknowledgments
This research was conducted with the UK Biobank Resource. We
thank Aida Andres, Hernan Burbano, Roger Mundry, Svante
Pa¨a¨bo, Martin Petr, Kay Pru¨fer, David Reich, Sriram Sankararaman,
Joshua Schmidt, and Benjamin Vernot for useful discussions and
the multimedia department of the Max Planck Institute for Evolu-
tionary Anthropology for help with figure preparation. Financial
support for this study was provided by the Max Planck Society.
Received: June 8, 2017
Accepted: September 5, 2017
Published: October 5, 2017Web Resources
1000 Genomes, http://browser.1000genomes.org/index.html
dbSNP, https://www.ncbi.nlm.nih.gov/projects/SNP/




UK Biobank genotyping and quality controls, https://biobank.
ctsu.ox.ac.uk/crystal/docs/genotyping_qc.pdfReferences
1. Fu, Q., Posth, C., Hajdinjak, M., Petr, M., Mallick, S.,
Fernandes, D., Furtwa¨ngler, A., Haak, W., Meyer, M., Mittnik,
A., et al. (2016). The genetic history of Ice Age Europe. Nature
534, 200–205.
2. Harris, K., and Nielsen, R. (2016). The genetic cost of Neander-
thal introgression. Genetics 203, 881–891.
3. Juric, I., Aeschbacher, S., and Coop, G. (2016). The strength of
selection against Neanderthal introgression. PLoS Genet. 12,
e1006340.n Journal of Human Genetics 101, 578–589, October 5, 2017 587
4. Sankararaman, S., Mallick, S., Dannemann, M., Pru¨fer, K.,
Kelso, J., Pa¨a¨bo, S., Patterson, N., and Reich, D. (2014). The
genomic landscape of Neanderthal ancestry in present-day
humans. Nature 507, 354–357.
5. Dannemann, M., Andre´s, A.M., and Kelso, J. (2016). Introgres-
sion of Neandertal- and Denisovan-like haplotypes contrib-
utes to adaptive variation in human Toll-like receptors. Am.
J. Hum. Genet. 98, 22–33.
6. Gittelman, R.M., Schraiber, J.G., Vernot, B., Mikacenic, C.,
Wurfel, M.M., and Akey, J.M. (2016). Archaic hominin admix-
ture facilitated adaptation to out-of-Africa environments.
Curr. Biol. 26, 3375–3382.
7. Mendez, F.L., Watkins, J.C., and Hammer, M.F. (2013). Nean-
dertal origin of genetic variation at the cluster of OAS immu-
nity genes. Mol. Biol. Evol. 30, 798–801.
8. Quach, H., Rotival, M., Pothlichet, J., Loh, Y.E., Dannemann,
M., Zidane, N., Laval, G., Patin, E., Harmant, C., Lopez, M.,
et al. (2016). Genetic adaptation and Neandertal admixture
shaped the immune system of human populations. Cell 167,
643–656.e17.
9. Racimo, F., Sankararaman, S., Nielsen, R., and Huerta-Sa´nchez,
E. (2015). Evidence for archaic adaptive introgression in hu-
mans. Nat. Rev. Genet. 16, 359–371.
10. Sams, A.J., Dumaine, A., Ne´de´lec, Y., Yotova, V., Alfieri, C.,
Tanner, J.E., Messer, P.W., and Barreiro, L.B. (2016). Adaptively
introgressed Neandertal haplotype at the OAS locus function-
ally impacts innate immune responses in humans. Genome
Biol. 17, 246.
11. Vernot, B., and Akey, J.M. (2014). Resurrecting surviving
Neandertal lineages from modern human genomes. Science
343, 1017–1021.
12. Simonti, C.N., Vernot, B., Bastarache, L., Bottinger, E., Carrell,
D.S., Chisholm, R.L., Crosslin, D.R., Hebbring, S.J., Jarvik, G.P.,
Kullo, I.J., et al. (2016). The phenotypic legacy of admixture be-
tweenmodernhumans andNeandertals. Science351, 737–741.
13. Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P.,
Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M.,
et al. (2015). UK biobank: an open access resource for identi-
fying the causes of a wide range of complex diseases of middle
and old age. PLoS Med. 12, e1001779.
14. Auton, A., Brooks, L.D., Durbin, R.M., Garrison, E.P., Kang,
H.M., Korbel, J.O., Marchini, J.L., McCarthy, S., McVean,
G.A., Abecasis, G.R.; and 1000 Genomes Project Consortium
(2015). A global reference for human genetic variation. Nature
526, 68–74.
15. Pru¨fer, K., Racimo, F., Patterson, N., Jay, F., Sankararaman, S.,
Sawyer, S., Heinze, A., Renaud, G., Sudmant, P.H., de Filippo,
C., et al. (2014). The complete genome sequence of a Neander-
thal from the Altai Mountains. Nature 505, 43–49.
16. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira,
M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly,
M.J., and Sham, P.C. (2007). PLINK: a tool set for whole-
genome association and population-based linkage analyses.
Am. J. Hum. Genet. 81, 559–575.
17. McLaren, W., Gil, L., Hunt, S.E., Riat, H.S., Ritchie, G.R., Thor-
mann, A., Flicek, P., and Cunningham, F. (2016). The Ensembl
Variant Effect Predictor. Genome Biol. 17, 122.
18. Dannemann, M., Pru¨fer, K., and Kelso, J. (2017). Functional
implications of Neandertal introgression in modern humans.
Genome Biol. 18, 61.
19. Huerta-Sa´nchez, E., Jin, X., Asan, Bianba, Z., Peter, B.M.,
Vinckenbosch, N., Liang, Y., Yi, X., He, M., Somel, M., et al.588 The American Journal of Human Genetics 101, 578–589, Octobe(2014). Altitude adaptation in Tibetans caused by introgres-
sion of Denisovan-like DNA. Nature 512, 194–197.
20. Hinds, D.A., McMahon, G., Kiefer, A.K., Do, C.B., Eriksson, N.,
Evans, D.M., St Pourcain, B., Ring, S.M., Mountain, J.L.,
Francke, U., et al. (2013). A genome-wide association meta-
analysis of self-reported allergy identifies shared and allergy-
specific susceptibility loci. Nat. Genet. 45, 907–911.
21. Bastiaens, M.T., ter Huurne, J.A., Kielich, C., Gruis, N.A., West-
endorp, R.G., Vermeer, B.J., Bavinck, J.N.; and Leiden Skin
Cancer Study Team (2001). Melanocortin-1 receptor gene
variants determine the risk of nonmelanoma skin cancer inde-
pendently of fair skin and red hair. Am. J. Hum. Genet. 68,
884–894.
22. Box, N.F., Wyeth, J.R., O’Gorman, L.E., Martin, N.G., and
Sturm, R.A. (1997). Characterization of melanocyte stimu-
lating hormone receptor variant alleles in twins with red
hair. Hum. Mol. Genet. 6, 1891–1897.
23. Flanagan, N., Healy, E., Ray, A., Philips, S., Todd, C., Jackson,
I.J., Birch-Machin, M.A., and Rees, J.L. (2000). Pleiotropic ef-
fects of the melanocortin 1 receptor (MC1R) gene on human
pigmentation. Hum. Mol. Genet. 9, 2531–2537.
24. Harding, R.M., Healy, E., Ray, A.J., Ellis, N.S., Flanagan, N.,
Todd, C., Dixon, C., Sajantila, A., Jackson, I.J., Birch-
Machin, M.A., and Rees, J.L. (2000). Evidence for variable
selective pressures at MC1R. Am. J. Hum. Genet. 66, 1351–
1361.
25. Sturm, R.A., Box, N.F., and Ramsay, M. (1998). Human
pigmentation genetics: the difference is only skin deep. Bio-
Essays 20, 712–721.
26. Sturm, R.A., Teasdale, R.D., and Box, N.F. (2001). Human
pigmentation genes: identification, structure and conse-
quences of polymorphic variation. Gene 277, 49–62.
27. Valverde, P., Healy, E., Jackson, I., Rees, J.L., and Thody, A.J.
(1995). Variants of the melanocyte-stimulating hormone re-
ceptor gene are associated with red hair and fair skin in hu-
mans. Nat. Genet. 11, 328–330.
28. Valverde, P., Healy, E., Sikkink, S., Haldane, F., Thody, A.J., Car-
others, A., Jackson, I.J., and Rees, J.L. (1996). The Asp84Glu
variant of the melanocortin 1 receptor (MC1R) is associated
with melanoma. Hum. Mol. Genet. 5, 1663–1666.
29. Lalueza-Fox, C., Ro¨mpler, H., Caramelli, D., Sta¨ubert, C.,
Catalano, G., Hughes, D., Rohland, N., Pilli, E., Longo, L.,
Condemi, S., et al. (2007). A melanocortin 1 receptor allele
suggests varying pigmentation among Neanderthals. Science
318, 1453–1455.
30. Jacobs, L.C., Wollstein, A., Lao, O., Hofman, A., Klaver, C.C.,
Uitterlinden, A.G., Nijsten, T., Kayser, M., and Liu, F. (2013).
Comprehensive candidate gene study highlights UGT1A
and BNC2 as new genes determining continuous skin color
variation in Europeans. Hum. Genet. 132, 147–158.
31. Field, Y., Boyle, E.A., Telis, N., Gao, Z., Gaulton, K.J., Golan, D.,
Yengo, L., Rocheleau, G., Froguel, P., McCarthy, M.I., and
Pritchard, J.K. (2016). Detection of human adaptation during
the past 2000 years. Science 354, 760–764.
32. Wray, N.R., Yang, J., Hayes, B.J., Price, A.L., Goddard, M.E.,
and Visscher, P.M. (2013). Pitfalls of predicting complex traits
from SNPs. Nat. Rev. Genet. 14, 507–515.
33. Roenneberg, T., Wirz-Justice, A., and Merrow, M. (2003). Life
between clocks: daily temporal patterns of human chrono-
types. J. Biol. Rhythms 18, 80–90.
34. Hu, Y., Shmygelska, A., Tran, D., Eriksson, N., Tung, J.Y., and
Hinds, D.A. (2016). GWAS of 89,283 individuals identifiesr 5, 2017
genetic variants associated with self-reporting of being a
morning person. Nat. Commun. 7, 10448.
35. Lane, J.M., Vlasac, I., Anderson, S.G., Kyle, S.D., Dixon, W.G.,
Bechtold, D.A., Gill, S., Little, M.A., Luik, A., Loudon, A., et al.
(2016). Genome-wide association analysis identifies novel loci
for chronotype in 100,420 individuals from the UK Biobank.
Nat. Commun. 7, 10889.
36. Mallick, S., Li, H., Lipson, M., Mathieson, I., Gymrek, M.,
Racimo, F., Zhao, M., Chennagiri, N., Nordenfelt, S., Tan-The Americadon, A., et al. (2016). The Simons Genome Diversity Project:
300 genomes from 142 diverse populations. Nature 538,
201–206.
37. Adan, A., Archer, S.N., Hidalgo, M.P., Di Milia, L., Natale, V.,
and Randler, C. (2012). Circadian typology: a comprehensive
review. Chronobiol. Int. 29, 1153–1175.
38. Jablonski, N.G., and Chaplin, G. (2010). Colloquium paper:
human skin pigmentation as an adaptation to UV radiation.
Proc. Natl. Acad. Sci. USA 107 (Suppl 2 ), 8962–8968.n Journal of Human Genetics 101, 578–589, October 5, 2017 589
The American Journal of Human Genetics, Volume 101Supplemental DataThe Contribution of Neanderthals
to Phenotypic Variation in Modern Humans































































































































































































































































































































































Figure S1:Divergence of the core haplotypes inferred for each of the 
archaic tag SNPs with significant phenotype associations.
We inferred core haplotypes (roman numerals) for each of the archaic tag SNPs with significant phenotype associations (Panels A-M) 
in the Phase III 1000 genomes individuals and computed neighbor-joining trees for these core haplotypes together with the genome 
sequences of the Altai Neandertal and the Denisovan and using the genome sequence of the chimpanzee as outgroup (Materials and 
Methods). Bootstrap values for the topology are shown in blue squares at each node (1,000 replicates). The number of times each 
core haplotype was observed in the 1000 genomes individuals is given on each branch alongside a pie chart illustrating the frequency 
of the core haplotype in each of the five continental super-populations. Core haplotype clusters to which haplotypes carrying the 
archaic allele for the archaic tag SNP are assigned are displayed with an additional pie chart showing the proportion of haplotypes 
in the cluster carrying the archaic allele (black) as well as the absolute number of haplotypes in the core haplotype cluster. Core 
haplotypes with fewer than 10 haplotypes assigned, are not shown.
Table S1: Table of phenotypes from the UK biobank.
Phenotype Meta phenotype Data type Number of individuals Complex phenotype
Alcohol drinker status Alcohol categorical 112338
Alcohol intake frequency. Alcohol categorical 112338
Absence of notch position in the pulse waveform Arterial stiffness 36580
Arterial pulse-wave stiffness device ID Arterial stiffness 2014
Arterial stiffness device ID Arterial stiffness 36982
Position of pulse wave notch Arterial stiffness 36580
Position of the pulse wave peak Arterial stiffness 36580
Position of the shoulder on the pulse waveform Arterial stiffness 36580
Pulse rate Arterial stiffness 36580
Pulse wave Arterial Stiffness index Arterial stiffness 36491
Pulse wave peak to peak time Arterial stiffness 36563
Pulse wave pressure versus time response curve Arterial stiffness 36580
Pulse wave reflection index Arterial stiffness 36580
Pulse wave velocity (manual entry) Arterial stiffness 39
Reason for skipping arterial stiffness Arterial stiffness 185
Stiffness method Arterial stiffness 36982
Auto-refraction method (right) Autorefraction 24042
Reason for skipping refractometry (left) Autorefraction 304
Reason for skipping refractometry (right) Autorefraction 263
Age at recruitment Baseline characteristics 112338
Month of birth Baseline characteristics 112338
Sex Baseline characteristics 112338
Townsend deprivation index at recruitment Baseline characteristics 112192
Year of birth Baseline characteristics 112338
Blood pressure device ID Blood pressure 112242
Blood pressure manual sphygmomanometer device ID Blood pressure 2119
Diastolic blood pressure, automated reading Blood pressure continuous 104611
Diastolic blood pressure, manual reading Blood pressure X
Method of measuring blood pressure Blood pressure X
Pulse rate (during blood-pressure measurement) Blood pressure X
Pulse rate, automated reading Blood pressure continuous 104611
Systolic blood pressure, automated reading Blood pressure continuous 104611
Systolic blood pressure, manual reading Blood pressure X
Time since interview start at which blood pressure screen(s) shown Blood pressure X
Arm fat mass (left)
Body composition by DXA/Impedance 
measures continuous 110379
Arm fat mass (right)
Body composition by DXA/Impedance 
measures continuous 110407
Leg fat mass (left)
Body composition by DXA/Impedance 
measures continuous 110420
Leg fat mass (right)
Body composition by DXA/Impedance 
measures continuous 110426
Trunk fat mass
Body composition by DXA/Impedance 
measures continuous 110362
Hip circumference Body size measures continuous 112173
Reason for skipping hip measurement Body size measures 92
Reason for skipping sitting height Body size measures 119
Reason for skipping standing height Body size measures 118
Reason for skipping waist Body size measures 84
Reason for skipping weight Body size measures 198
Sitting height Body size measures continuous 112063
Standing height Body size measures continuous 112147
Waist circumference Body size measures continuous 112181
Weight method Body size measures 112265
Weight, manual entry Body size measures 1630
Body mass index (BMI)
Body size measures/Impedance 
measures continuous 112027
Weight
Body size measures/Impedance 
measures continuous 112065
Table S1: Table of phenotypes from the UK biobank.
Phenotype Meta phenotype Data type Number of individuals Complex phenotype
Ankle spacing width Bone-densitometry of heel 64971
Ankle spacing width (left) Bone-densitometry of heel 35265
Ankle spacing width (right) Bone-densitometry of heel 35266
Foot measured for bone density Bone-densitometry of heel 74584
Fractured heel Bone-densitometry of heel 74584
Fractured heel (left) Bone-densitometry of heel 35565
Fractured heel (right) Bone-densitometry of heel 35580
Heel bone mineral density (BMD) Bone-densitometry of heel 64940
Heel bone mineral density (BMD) (left) Bone-densitometry of heel 35247
Heel bone mineral density (BMD) (right) Bone-densitometry of heel 35248
Heel bone mineral density (BMD) T-score, automated Bone-densitometry of heel 64971
Heel bone mineral density (BMD) T-score, automated (left) Bone-densitometry of heel 35265
Heel bone mineral density (BMD) T-score, automated (right) Bone-densitometry of heel 35266
Heel bone mineral density (BMD) T-score, manual entry (left) Bone-densitometry of heel 299
Heel bone mineral density (BMD) T-score, manual entry (right) Bone-densitometry of heel 313
Heel bone mineral density (BMD), manual entry Bone-densitometry of heel 9607
Heel bone mineral density (BMD), manual entry (left) Bone-densitometry of heel 299
Heel bone mineral density (BMD), manual entry (right) Bone-densitometry of heel 313
Heel bone ultrasound T-score, manual entry Bone-densitometry of heel 9607
Heel Broadband ultrasound attenuation (BUA), manual entry Bone-densitometry of heel 9607
Heel broadband ultrasound attenuation (BUA), manual entry (left) Bone-densitometry of heel 299
Heel broadband ultrasound attenuation (BUA), manual entry (right) Bone-densitometry of heel 313
Heel broadband ultrasound attenuation (left) Bone-densitometry of heel 35259
Heel broadband ultrasound attenuation (right) Bone-densitometry of heel 35265
Heel Broadband ultrasound attenuation, direct entry Bone-densitometry of heel 64971
Heel quantitative ultrasound index (QUI), direct entry Bone-densitometry of heel 64971
Heel quantitative ultrasound index (QUI), direct entry (left) Bone-densitometry of heel 35265
Heel quantitative ultrasound index (QUI), direct entry (right) Bone-densitometry of heel 35266
Heel quantitative ultrasound index (QUI), manual entry Bone-densitometry of heel 9607
Heel quantitative ultrasound index (QUI), manual entry (left) Bone-densitometry of heel 299
Heel quantitative ultrasound index (QUI), manual entry (right) Bone-densitometry of heel 313
Heel ultrasound method Bone-densitometry of heel 75236
Heel ultrasound method (left) Bone-densitometry of heel 36946
Heel ultrasound method (right) Bone-densitometry of heel 36946
Shortness of breath walking on level ground Breathing 36987
Wheeze or whistling in the chest in last year Breathing continuous 112337
Age at cancer diagnosis Cancer register 14915
Behaviour of cancer tumour Cancer register 14707
Date of cancer diagnosis Cancer register 14915
Histology of cancer tumour Cancer register 14558
Reported occurrences of cancer Cancer register 14915
Type of cancer: ICD10 Cancer register 12595
Type of cancer: ICD9 Cancer register 2320
Ever had bowel cancer screening Cancer screening 112336
Ever had prostate specific antigen (PSA) test Cancer screening 53326
Most recent bowel cancer screening Cancer screening 35401
Time since last prostate specific antigen (PSA) test Cancer screening 15773
Chest pain due to walking ceases when standing still Chest pain 7166
Chest pain or discomfort Chest pain continuous 112336
Chest pain or discomfort walking normally Chest pain 17962
Chest pain or discomfort when walking uphill or hurrying Chest pain 14633
Leg pain in calf/calves
Claudication and peripheral artery 
disease 8286
Leg pain on walking
Claudication and peripheral artery 
disease 36987
Table S1: Table of phenotypes from the UK biobank.
Phenotype Meta phenotype Data type Number of individuals Complex phenotype
Leg pain on walking : action taken
Claudication and peripheral artery 
disease 8286
Leg pain on walking : effect of standing still
Claudication and peripheral artery 
disease 8286
Leg pain when standing still or sitting
Claudication and peripheral artery 
disease 8286
Leg pain when walking ever disappears while walking
Claudication and peripheral artery 
disease 4682
Leg pain when walking normally
Claudication and peripheral artery 
disease 8286
Leg pain when walking uphill or hurrying
Claudication and peripheral artery 
disease 8286
Surgery on leg arteries (other than for varicose veins)
Claudication and peripheral artery 
disease 8286
Surgery/amputation of toe or leg
Claudication and peripheral artery 
disease 8286
Age at death Death register 2049
Contributory (secondary) causes of death: ICD10 Death register X
Date of death Death register 2049
Description of cause of death Death register 1733
Underlying (primary) cause of death: ICD10 Death register 2048
Age when last ate meat Diet 3954
Bread intake Diet continuous 112254
Bread type Diet categorical 108831
Bread type/intake (pilot) Diet 83
Cereal intake Diet continuous 112337
Cereal type Diet categorical 93149
Cheese intake Diet categorical 109960
Coffee intake Diet continuous 112338
Coffee type Diet categorical 88164
Cooked vegetable intake Diet continuous 112338
Fresh fruit intake Diet continuous 112338
Hot drink temperature Diet categorical 112338
Lamb/mutton intake Diet categorical 112338
Major dietary changes in the last 5 years Diet categorical 112338
Milk type used Diet categorical 112336
Never eat eggs, dairy, wheat, sugar Diet X
Never eat eggs, dairy, wheat, sugar (pilot) Diet X
Non-butter spread type details Diet 59603
Non-oily fish intake Diet categorical 112338
Processed meat intake Diet categorical 112338
Salad / raw vegetable intake Diet continuous 112338
Salt added to food Diet categorical 112338
Spread type Diet categorical 112254
Spread type (pilot) Diet 84
Tea intake Diet continuous 112338
Variation in diet Diet categorical 112254
Water intake Diet continuous 112338
Dried fruit intake Diet/Fruit/vegetables yesterday continuous 112338
Beef intake Diet/Meat/fish yesterday categorical 112338
Oily fish intake Diet/Meat/fish yesterday categorical 112338
Pork intake Diet/Meat/fish yesterday categorical 112338
Poultry intake Diet/Meat/fish yesterday categorical 112338
Comparative body size at age 10 Early life factors categorical 112338
Comparative height size at age 10 Early life factors categorical 112338
Handedness (chirality/laterality) Early life factors categorical 112338
Part of a multiple birth Early life factors categorical 110757
Able to walk or cycle unaided for 10 minutes ECG during exercise 16527
Chest pain felt during physical activity ECG during exercise 16527
Table S1: Table of phenotypes from the UK biobank.
Phenotype Meta phenotype Data type Number of individuals Complex phenotype
Chest pain felt outside physical activity ECG during exercise 16527
Completion status of test ECG during exercise 16259
Doctor restricts physical activity due to heart condition ECG during exercise 16527
Duration of fitness test ECG during exercise 16254
ECG, heart rate ECG during exercise X
ECG, load ECG during exercise X
ECG, number of stages in a phase ECG during exercise X
ECG, phase duration ECG during exercise X
ECG, phase name ECG during exercise X
ECG, phase time ECG during exercise X
ECG, stage duration ECG during exercise 0
ECG, stage name ECG during exercise X
ECG, trend phase name ECG during exercise X
ECG/bike method for fitness test ECG during exercise 16475
Maximum heart rate during fitness test ECG during exercise 16249
Maximum workload during fitness test ECG during exercise 16254
Number of trend entries ECG during exercise 16254
Program category ECG during exercise 16527
Reason at-rest ECG performed without bicycle ECG during exercise 191
Reason ECG not completed ECG during exercise 44
Reason for skipping ECG ECG during exercise 79
Target heart rate achieved ECG during exercise 16254
Qualifications Education X
Length of mobile phone use Electronic device use 112338
Ethnic background Ethnicity 112338
Both eyes present Eye surgery/complications 24334
Current eye infection Eye surgery/complications 24333
Ever had cataract surgery Eye surgery/complications 1714
Ever had corneal graft surgery Eye surgery/complications 1714
Ever had eye surgery Eye surgery/complications 24334
Ever had laser treatment for glaucoma or high eye pressure Eye surgery/complications 1714
Ever had refractive laser eye surgery Eye surgery/complications 1714
Ever had surgery for glaucoma or high eye pressure Eye surgery/complications 1714
Age at first live birth Female-specific factors 40126
Age of primiparous women at birth of child Female-specific factors 7907
Ever had stillbirth, spontaneous miscarriage or termination Female-specific factors 59010
Ever taken oral contraceptive pill Female-specific factors 59010
Length of menstrual cycle Female-specific factors 12883
Number of live births Female-specific factors 59010
Number of spontaneous miscarriages Female-specific factors 18626
Number of stillbirths Female-specific factors 18626
Attempted fluid intelligence (FI) test. Fluid intelligence test 36539
FI1 : numeric addition test
Fluid intelligence test/Fluid intelligence 
test 36093
FI10 : arithmetic sequence recognition
Fluid intelligence test/Fluid intelligence 
test 7577
FI11 : antonym
Fluid intelligence test/Fluid intelligence 
test 3921
FI12 : square sequence recognition
Fluid intelligence test/Fluid intelligence 
test 2732
FI13 : subset inclusion logic
Fluid intelligence test/Fluid intelligence 
test 981
FI2 : identify largest number
Fluid intelligence test/Fluid intelligence 
test 36029
FI3 : word interpolation
Fluid intelligence test/Fluid intelligence 
test 36013
FI4 : positional arithmetic
Fluid intelligence test/Fluid intelligence 
test 35982
FI5 : family relationship calculation
Fluid intelligence test/Fluid intelligence 
test 35339
Table S1: Table of phenotypes from the UK biobank.
Phenotype Meta phenotype Data type Number of individuals Complex phenotype
FI6 : conditional arithmetic
Fluid intelligence test/Fluid intelligence 
test 31902
FI7 : synonym
Fluid intelligence test/Fluid intelligence 
test 26207
FI8 : chained arithmetic
Fluid intelligence test/Fluid intelligence 
test 23796
FI9 : concept interpolation
Fluid intelligence test/Fluid intelligence 
test 11078
Fluid intelligence score
Fluid intelligence test/Fluid intelligence 
test 36093
Falls in the last year General health categorical 112337
Long-standing illness, disability or infirmity General health categorical 112337
Overall health rating General health categorical 112337
Weight change compared with 1 year ago General health categorical 112337
Hand grip strength (left) Hand grip strength continuous 111875
Hand grip strength (right) Hand grip strength continuous 111876
Reason for skipping grip strength (left) Hand grip strength 390
Reason for skipping grip strength (right) Hand grip strength 389
Speech-reception-threshold (SRT) estimate (left) Hearing test 35290
Speech-reception-threshold (SRT) estimate (right) Hearing test 35279
Arm fat percentage (left) Impedance measures continuous 110394
Arm fat percentage (right) Impedance measures continuous 110413
Arm fat-free mass (left) Impedance measures continuous 110380
Arm fat-free mass (right) Impedance measures continuous 110398
Arm predicted mass (left) Impedance measures continuous 110378
Arm predicted mass (right) Impedance measures continuous 110397
Basal metabolic rate Impedance measures continuous 110432
Body fat percentage Impedance measures continuous 110365
Impedance of arm (left) Impedance measures continuous 110426
Impedance of arm (right) Impedance measures continuous 110422
Impedance of leg (left) Impedance measures continuous 110428
Impedance of leg (right) Impedance measures continuous 110429
Impedance of whole body Impedance measures continuous 110426
Leg fat percentage (left) Impedance measures continuous 110421
Leg fat percentage (right) Impedance measures continuous 110428
Leg fat-free mass (left) Impedance measures continuous 110416
Leg fat-free mass (right) Impedance measures continuous 110424
Leg predicted mass (left) Impedance measures continuous 110414
Leg predicted mass (right) Impedance measures continuous 110424
Trunk fat percentage Impedance measures continuous 110368
Trunk fat-free mass Impedance measures continuous 110343
Trunk predicted mass Impedance measures continuous 110327
Whole body fat mass Impedance measures continuous 110243
Whole body fat-free mass Impedance measures continuous 110423
Whole body water mass Impedance measures continuous 110434
Applanation curve (left) Intraocular pressure 23181
Applanation curve (right) Intraocular pressure 23240
Corneal hysteresis (left) Intraocular pressure 23181
Corneal hysteresis (right) Intraocular pressure 23240
Corneal resistance factor (left) Intraocular pressure 23181
Corneal resistance factor (right) Intraocular pressure 23240
Intra-ocular pressure (IOP) method (left) Intraocular pressure 24040
Intra-ocular pressure (IOP) method (right) Intraocular pressure 24042
Intra-ocular pressure, corneal-compensated (left) Intraocular pressure 23181
Intra-ocular pressure, corneal-compensated (right) Intraocular pressure 23240
Intra-ocular pressure, Goldmann-correlated (left) Intraocular pressure 23181
Intra-ocular pressure, Goldmann-correlated (right) Intraocular pressure 23240
Table S1: Table of phenotypes from the UK biobank.
Phenotype Meta phenotype Data type Number of individuals Complex phenotype
Pressure curve (left) Intraocular pressure 23181
Pressure curve (right) Intraocular pressure 23240
Reason for skipping IOP (left) Intraocular pressure 496
Reason for skipping IOP (right) Intraocular pressure 457
Hair/balding pattern Male-specific factors 53283
Number of children fathered Male-specific factors 53283
Relative age of first facial hair Male-specific factors 53283
Relative age voice broke Male-specific factors 53283
Cancer code, self-reported Medical conditions X
Cancer year/age first occurred Medical conditions X
Interpolated Age of participant when cancer first diagnosed Medical conditions continuous 84969
Interpolated Age of participant when non-cancer illness first diagnosed Medical conditions continuous 84969
Interpolated Year when cancer first diagnosed Medical conditions X
Interpolated Year when non-cancer illness first diagnosed Medical conditions X
Method of recording time when cancer first diagnosed Medical conditions X
Method of recording time when non-cancer illness first diagnosed Medical conditions X
Non-cancer illness code, self-reported Medical conditions X
Non-cancer illness year/age first occurred Medical conditions continuous 84969
Number of self-reported cancers Medical conditions continuous 112327
Number of self-reported non-cancer illnesses Medical conditions continuous 112327
Pregnant Medical conditions 58968
Bipolar and major depression status Mental health 26838
Bipolar disorder status Mental health 333
Ever depressed for a whole week Mental health 36987
Ever highly irritable/argumentative for 2 days Mental health 36987
Ever manic/hyper for 2 days Mental health 36987
Ever unenthusiastic/disinterested for a whole week Mental health 36987
Family relationship satisfaction Mental health 36987
Fed-up feelings Mental health categorical 112337
Financial situation satisfaction Mental health 36987
Frequency of depressed mood in last 2 weeks Mental health categorical 112337
Frequency of tenseness / restlessness in last 2 weeks Mental health categorical 112337
Frequency of tiredness / lethargy in last 2 weeks Mental health categorical 112337
Frequency of unenthusiasm / disinterest in last 2 weeks Mental health categorical 112337
Friendships satisfaction Mental health 36987
Guilty feelings Mental health categorical 112337
Happiness Mental health 36987
Health satisfaction Mental health 36987
Illness, injury, bereavement, stress in last 2 years Mental health categorical 112253
Illness, injury, bereavement, stress in last 2 years (pilot) Mental health X
Irritability Mental health categorical 112337
Length of longest manic/irritable episode Mental health 7593
Loneliness, isolation Mental health categorical 112337
Longest period of depression Mental health 19426
Longest period of unenthusiasm / disinterest Mental health 13101
Manic/hyper symptoms Mental health X
Miserableness Mental health categorical 112337
Mood swings Mental health categorical 112337
Nervous feelings Mental health categorical 112337
Neuroticism score Mental health continuous 91620
Number of depression episodes Mental health 19426
Number of unenthusiastic/disinterested episodes Mental health 13101
Probable recurrent major depression (moderate) Mental health 3432
Probable recurrent major depression (severe) Mental health 2040
Table S1: Table of phenotypes from the UK biobank.
Phenotype Meta phenotype Data type Number of individuals Complex phenotype
Risk taking Mental health categorical 112337
Seen a psychiatrist for nerves, anxiety, tension or depression Mental health categorical 112337
Seen doctor (GP) for nerves, anxiety, tension or depression Mental health categorical 112337
Sensitivity / hurt feelings Mental health categorical 112337
Severity of manic/irritable episodes Mental health 7593
Single episode of probable major depression Mental health 2250
Suffer from 'nerves' Mental health categorical 112337
Tense / 'highly strung' Mental health categorical 112337
Work/job satisfaction Mental health 36987
Worrier / anxious feelings Mental health categorical 112337
Worry too long after embarrassment Mental health categorical 112337
Mouth/teeth dental problems Mouth categorical 112253
Mouth/teeth dental problems (pilot) Mouth X
Back pain for 3+ months Pain 28709
Facial pains for 3+ months Pain 2023
General pain for 3+ months Pain 1769
Headaches for 3+ months Pain 22091
Hip pain for 3+ months Pain 12995
Knee pain for 3+ months Pain 24373
Neck/shoulder pain for 3+ months Pain 25998
Pain type(s) experienced in last month Pain categorical 112336
Stomach/abdominal pain for 3+ months Pain 9556
Number of incorrect matches in round
Pairs matching test/Pairs matching 
test X
Frequency of heavy DIY in last 4 weeks Physical activity 48818
Frequency of light DIY in last 4 weeks Physical activity 57730
Frequency of other exercises in last 4 weeks Physical activity 53000
Frequency of stair climbing in last 4 weeks Physical activity categorical 111878
Frequency of strenuous sports in last 4 weeks Physical activity 11008
Frequency of walking for pleasure in last 4 weeks Physical activity categorical 79141
Number of days/week walked 10+ minutes Physical activity categorical 112338
Types of physical activity in last 4 weeks Physical activity categorical 111935
Usual walking pace Physical activity categorical 111962
Duration screen displayed Prospective memory test 36850
Final attempt correct Prospective memory test 36850
History of attempts Prospective memory test 36850
Number of attempts Prospective memory test 36850
PM: final answer Prospective memory test 36850
PM: initial answer Prospective memory test 36850
Prospective memory result Prospective memory test 36850
Test completion status Prospective memory test 36850
Time screen exited Prospective memory test 36850
Time to answer Prospective memory test 36850
Time when initial screen shown Prospective memory test 36850
Age when attended assessment centre Reception 112338
Date of attending assessment centre Reception 112338
UK Biobank assessment centre Reception 112338
OCT measured (left) Retinal optical coherence tomography 16533
OCT measured (right) Retinal optical coherence tomography 16531
Reason for skipping OCT (left) Retinal optical coherence tomography 716
Reason for skipping OCT (right) Retinal optical coherence tomography 675
Age first had sexual intercourse Sexual factors continuous 103379
Answered sexual history questions Sexual factors 112337
Ever had same-sex intercourse Sexual factors categorical 102415
Lifetime number of same-sex sexual partners Sexual factors 3374
Table S1: Table of phenotypes from the UK biobank.
Phenotype Meta phenotype Data type Number of individuals Complex phenotype
Lifetime number of sexual partners Sexual factors continuous 102415
Daytime dozing / sleeping (narcolepsy) Sleep categorical 112338
Getting up in morning Sleep categorical 112254
Morning/evening person (chronotype) Sleep categorical 112254
Nap during day Sleep categorical 112338
Sleep duration Sleep continuous 112338
Sleeplessness / insomnia Sleep categorical 112338
Snoring Sleep categorical 112338
Smoking status Smoking categorical 112338
Episodes containing "Diagnoses - main ICD10 - addendum" data Spell and Episode Data (diagnoses) 458
Episodes containing "Diagnoses - main ICD10" data Spell and Episode Data (diagnoses) 79357
Episodes containing "Diagnoses - secondary ICD10 addendum" data Spell and Episode Data (diagnoses) 550
Episodes containing "Diagnoses - secondary ICD10" data Spell and Episode Data (diagnoses) 59042
Episodes containing "External cause - ICD10 addendum" data Spell and Episode Data (diagnoses) 56
Episodes containing "External cause - ICD10" data Spell and Episode Data (diagnoses) 10661
Acceptability of each blow result (text) Spirometry X
Acceptability of each blow result (text) (pilot) Spirometry X
Caffeine drink within last hour Spirometry categorical 105523
Contra-indications for spirometry Spirometry categorical 112265
Data points for blow Spirometry X
Data points for blow (pilot) Spirometry X
Forced expiratory volume in 1-second (FEV1) Spirometry X
Forced expiratory volume in 1-second (FEV1) (pilot) Spirometry X
Forced expiratory volume in 1-second (FEV1), Best measure Spirometry continuous 91907
Forced expiratory volume in 1-second (FEV1), predicted Spirometry 56611
Forced expiratory volume in 1-second (FEV1), predicted percentage Spirometry 56611
Forced vital capacity (FVC) Spirometry X
Forced vital capacity (FVC) (pilot) Spirometry X
Forced vital capacity (FVC), Best measure Spirometry continuous 91907
Number of measurements made Spirometry 104956
Ordering of blows Spirometry X
Peak expiratory flow (PEF) Spirometry X
Peak expiratory flow (PEF) (pilot) Spirometry X
Reason for skipping spirometry Spirometry 339
Reproduciblity of spirometry measurement using ERS/ATS criteria Spirometry 91907
Result ranking Spirometry X
Result ranking (pilot) Spirometry X
Smoked cigarette or pipe within last hour Spirometry 12758
Spirometry method Spirometry 105444
Spirometry method (pilot) Spirometry 79
Used an inhaler for chest within last hour Spirometry 105523
Diagnoses - main ICD10 Summary Information (diagnoses) X
Diagnoses - secondary ICD10 Summary Information (diagnoses) X
External causes Summary Information (diagnoses) X
History of psychiatric care on admission Summary Information (psychiatric) X
Mental categories Summary Information (psychiatric) X
Childhood sunburn occasions Sun exposure continuous 112254
Ease of skin tanning Sun exposure categorical 112254
Facial ageing Sun exposure categorical 112253
Hair colour (natural, before greying) Sun exposure categorical 112338
Skin colour Sun exposure categorical 112338
Time spend outdoors in summer Sun exposure continuous 112254
Time spent outdoors in winter Sun exposure continuous 112254
Glasses worn/required (left) Visual acuity 16640
Table S1: Table of phenotypes from the UK biobank.
Phenotype Meta phenotype Data type Number of individuals Complex phenotype
Glasses worn/required (right) Visual acuity 16656
logMAR, final (left) Visual acuity 23991
logMAR, final (right) Visual acuity 24002
Reason for skipping visual acuity (left) Visual acuity 96
Reason for skipping visual acuity (right) Visual acuity 78
Visual acuity measured (left) Visual acuity 24290
Visual acuity measured (right) Visual acuity 24292
Table includes all UK Biobank phenotypes to which we had access (column 1, with meta phenotype provided by UK biobank in column 2). The 136 
phenotypes included in this study are highlighted in bold. Column 3 provides format in which the 136 phenotype we included are represented and column 
4 the number of individuals selected for this study because both genotype and phenotype information were available (Material and Methods).  In Column 5 
phenotypes with complex measurements (i.e. phenotypes that do not have one single measurement) are marked with an ‘X’.




Pork intake <0.001 0.023 2 0.222 under-representation
Ease of skin tanning <0.001 0.023 5 0.364 under-representation
Smoking status <0.001 0.023 5 4.629 over-representation
Morning/evening person (chronotype) <0.001 0.023 3 22.22 over-representation
Loneliness, isolation <0.001 0.023 2 487.388 over-representation
Frequency of unenthusiasm / disinterest in last 
2 weeks 0.002 0.039 3 14.164 over-representation
Pain type(s) experienced in last month 0.004 0.052 4 0.399 under-representation
Number of days/week walked 10+ minutes 0.004 0.052 5 5.39 over-representation
Alcohol intake frequency. 0.004 0.052 4 7.162 over-representation
Water intake 0.008 0.077 3 13.83 over-representation
Body mass index (BMI) 0.01 0.077 13 2.268 over-representation
Handedness (chirality/laterality) 0.01 0.077 5 4.516 over-representation
Salad / raw vegetable intake 0.01 0.077 5 4.616 over-representation
Non-cancer illness year/age first occurred 0.01 0.077 4 5.814 over-representation
Frequency of tiredness / lethargy in last 2 
weeks 0.01 0.077 4 6.008 over-representation
Non-oily fish intake 0.012 0.082 1 0.28 under-representation
Coffee intake 0.012 0.082 1 163.265 over-representation
Bread intake 0.014 0.09 2 13.976 over-representation
Tea intake 0.016 0.095 1 122.401 over-representation
Processed meat intake 0.018 0.095 1 0.279 under-representation
Ever had same-sex intercourse 0.018 0.095 2 0.316 under-representation
Pulse rate, automated reading 0.018 0.095 10 2.339 over-representation
Alcohol drinker status 0.02 0.097 2 0.354 under-representation
Coffee type 0.02 0.097 3 6.111 over-representation
Daytime dozing / sleeping (narcolepsy) 0.022 0.102 3 6.412 over-representation
Caffeine drink within last hour 0.024 0.103 7 2.778 over-representation
Miserableness 0.024 0.103 1 81.376 over-representation
Seen a psychiatrist for nerves, anxiety, tension 
or depression 0.028 0.112 4 4.367 over-representation
Frequency of depressed mood in last 2 weeks 0.028 0.112 1 69.875 over-representation
Whole body fat-free mass 0.032 0.12 1 0.306 under-representation
Basal metabolic rate 0.032 0.12 2 0.376 under-representation
Trunk fat-free mass 0.036 0.13 1 0.292 under-representation
Trunk predicted mass 0.042 0.148 2 0.374 under-representation
Lifetime number of sexual partners 0.046 0.157 1 42.462 over-representation
Hand grip strength (left) 0.048 0.159 2 7.322 over-representation
Major dietary changes in the last 5 years 0.066 0.213 2 6.474 over-representation
Interpolated Year when non-cancer illness first 
diagnosed 0.074 0.232 1 25.718 over-representation
Standing height 0.076 0.232 1 0.324 under-representation
Childhood sunburn occasions 0.092 0.274 4 0.545 under-representation
Mouth/teeth dental problems 0.096 0.278 3 3.906 over-representation
Cheese intake 0.112 0.315 2 5.652 over-representation
Nap during day 0.114 0.315 3 3.568 over-representation




Types of physical activity in last 4 weeks 0.12 0.324 1 0.447 under-representation
Comparative height size at age 10 0.128 0.337 5 2.261 over-representation
Frequency of walking for pleasure in last 4 
weeks 0.134 0.341 2 4.687 over-representation
Frequency of tenseness / restlessness in last 2 
weeks 0.136 0.341 3 3.101 over-representation
Impedance of arm (left) 0.144 0.341 1 0.498 under-representation
Diastolic blood pressure, automated reading 0.146 0.341 3 0.568 under-representation
Arm fat percentage (right) 0.146 0.341 4 2.515 over-representation
Contra-indications for spirometry 0.148 0.341 1 0.478 under-representation
Impedance of leg (right) 0.15 0.341 5 0.595 under-representation
Leg predicted mass (right) 0.16 0.356 2 0.507 under-representation
Number of self-reported cancers 0.166 0.356 3 0.601 under-representation
Trunk fat mass 0.17 0.356 1 0.478 under-representation
Fed-up feelings 0.17 0.356 1 11.109 over-representation
Hair colour (natural, before greying) 0.172 0.356 9 0.706 under-representation
Leg fat-free mass (right) 0.178 0.359 2 0.513 under-representation
Time spend outdoors in summer 0.182 0.359 3 2.712 over-representation
Impedance of arm (right) 0.188 0.359 2 0.536 under-representation
Number of self-reported non-cancer illnesses 0.19 0.359 3 2.662 over-representation
Skin colour 0.192 0.359 4 0.662 under-representation
Forced expiratory volume in 1-second (FEV1), 
Best measure 0.192 0.359 2 3.833 over-representation
Leg fat mass (right) 0.204 0.375 5 1.986 over-representation
Sleeplessness / insomnia 0.208 0.375 2 3.675 over-representation
Interpolated Age of participant when non-
cancer illness first diagnosed 0.214 0.375 3 2.366 over-representation
Frequency of stair climbing in last 4 weeks 0.214 0.375 1 8.652 over-representation
Trunk fat percentage 0.218 0.375 3 2.465 over-representation
Leg fat-free mass (left) 0.22 0.375 2 0.561 under-representation
Leg predicted mass (left) 0.224 0.377 2 0.57 under-representation
Arm fat mass (left) 0.232 0.382 9 1.527 over-representation
Milk type used 0.234 0.382 1 0.581 under-representation
Lamb/mutton intake 0.238 0.383 3 0.595 under-representation
Facial ageing 0.244 0.388 5 1.772 over-representation
Poultry intake 0.26 0.402 4 1.951 over-representation
Overall health rating 0.26 0.402 2 3.076 over-representation
Impedance of whole body 0.266 0.406 1 0.736 under-representation
Fresh fruit intake 0.284 0.428 1 6.608 over-representation
Bread type 0.288 0.428 2 2.952 over-representation
Impedance of leg (left) 0.294 0.432 8 0.724 under-representation
Beef intake 0.298 0.432 3 2.231 over-representation
Whole body fat mass 0.304 0.435 2 0.626 under-representation
Arm fat mass (right) 0.32 0.447 6 1.568 over-representation
Never eat eggs, dairy, wheat, sugar 0.324 0.447 1 0.539 under-representation
Cereal intake 0.324 0.447 2 2.604 over-representation




Hot drink temperature 0.328 0.448 1 5.228 over-representation
Illness, injury, bereavement, stress in last 2 
years 0.348 0.469 2 2.643 over-representation
Hip circumference 0.364 0.485 2 0.703 under-representation
Mood swings 0.402 0.529 2 2.276 over-representation
Weight 0.41 0.529 3 0.714 under-representation
Sitting height 0.422 0.529 2 0.7 under-representation
Systolic blood pressure, automated reading 0.422 0.529 2 0.705 under-representation
Snoring 0.422 0.529 1 4.25 over-representation
Sleep duration 0.424 0.529 2 2.305 over-representation
Spread type 0.442 0.545 2 2.23 over-representation
Usual walking pace 0.448 0.547 1 1.012 under-representation
Neuroticism score 0.472 0.564 1 0.7 under-representation
Hand grip strength (right) 0.472 0.564 2 2.174 over-representation
Comparative body size at age 10 0.486 0.575 3 0.737 under-representation
Part of a multiple birth 0.512 0.6 2 1.973 over-representation
Leg fat mass (left) 0.522 0.605 1 0.756 under-representation
Forced vital capacity (FVC), Best measure 0.53 0.605 5 1.394 over-representation
Age first had sexual intercourse 0.532 0.605 1 3.155 over-representation
Waist circumference 0.538 0.605 1 3.292 over-representation
Cereal type 0.544 0.605 2 1.897 over-representation
Sensitivity / hurt feelings 0.548 0.605 1 3.064 over-representation
Arm fat percentage (left) 0.562 0.615 3 1.571 over-representation
Leg fat percentage (right) 0.568 0.616 3 1.612 over-representation
Cooked vegetable intake 0.6 0.641 2 1.865 over-representation
Wheeze or whistling in the chest in last year 0.602 0.641 2 1.814 over-representation
Dried fruit intake 0.642 0.675 2 0.9 under-representation
Salt added to food 0.646 0.675 1 2.42 over-representation
Body fat percentage 0.68 0.704 2 1.596 over-representation
Falls in the last year 0.686 0.704 1 0.905 under-representation
Risk taking 0.702 0.714 2 0.892 under-representation
Leg fat percentage (left) 0.714 0.72 2 1.625 over-representation
Long-standing illness, disability or infirmity 0.734 0.734 1 1.055 under-representation
For each phenotype (column 1) we show the empirical P value (column 2) for the comparison of the 
cumulative association P-value distribution (for P<10-4) for archaic alleles and 1,000 cumulative non-archaic 
allele association P-value distributions. The corresponding false discovery rates (column 3), the rank of the 
sorted set of archaic SNPs  (by P value) for which the archaic distribution has the largest distance to the mean 
non-archaic distributions (column 4) and the corresponding largest odds ratio between the archaic association 
P-value distributions (column 5) are provided.  Column 6 identifies whether the Neandertal alleles are under- 
or over-represented compared to non-archaic alleles based on the direction of enrichment.






33.19 Altai ref alt publication(s)
Val60Leu 89985844 rs1805005 G G G T 1,2,3,4,6,7 (1) Box et al., 1997
Ala64Ser 89985856 G G G T 5 (2) Sturm et al., 1998
Arg67Gln 89985866 rs34090186 G G G A 1,8 (3) Box et al., 2001b
Phe76Tyr 89985893 T T T A 5 (4) Flanagan et al., 2000
Ala81Pro 89985907 G G G C 7 (5) Valverde et al., 1995
Asp84Glu 89985918 rs1805006 C C C A 1,2,3,4,5,6,7 (6) Harding et al., 2000
Val92Met 89985940 rs2228479 G G G A 1,2,3,4,5,6,7 (7) Bastiaens et al., 2001
Thr95Met 89985950 C C C T 4,5,7 (8) Rana et al., 1999
Val97Ile 89985955 G G G A 5 (9) Lalueza-Fox et al. 2010
Ala103Val 89985974 C C C T 5
Gly104Ser 89985976 rs2229617 G G G A 7
Leu106Gln 89985983 T T T A 5
Arg142His 89986091 rs11547464 G G G A 1,2,3,4,7
Arg151Cys 89986117 rs1805007 C C C T 1,2,3,4,6,7
Ile155Thr 89986130 rs1110400 T T T C 1,2,3,4,6,7
Arg160Trp 89986144 rs1805008 C C C T 1,2,3,4,6,7
Arg163Gln 89986154 rs885479 G G G A 1,2,3,4,6,7,8
Val174Ile 89986186 G G G A 7
Pro230Leu 89986355 rs368714912 C C C T 7
His260Pro 89986445 A A A A 7
Val265Ile 89986459 rs587783376 G A G A
Lys278Glu 89986498 rs201171524 A A A G 7
Asn279Ser 89986502 rs376692024 A A A G 7
Ile287Met 89986527 rs373957223 C C C G 1,8
Asp294His 89986546 rs1805009 G G G C 1,2,3,4,5,6,7
Arg307Gly 89986586 G G G 9
Table includes previously reported non-synonymous variants which have been significantly associated with hair 
color variation and their genotype in two high-coverage Neandertals (columns 4,5).
Table S6: : Frequency of significantly associated Neandertal alleles in the UK biobank cohort and 1,000 Genomes (phase III) populations
UK biobank CEU TSI FIN GBR IBS CHB JPT CHS CDX KHV GIH PJL BEB STU ITU YRI LWK GWD MSL ESN ASW ACB MXL PUR CLM PEL
chr2:239316043 12.4 13.6 8.3 18.2 13.6 10.3 7.8 2.4 5.1 4.5 5 8 5.7 2.3 3.4 3.4 0 0 0 0 0 0.8 1.6 3.7 7.6 4.3 2.3
chr6:121947984 2.9 3 4.2 3.5 3.3 3.3 10.7 9.1 14.4 17.2 16.8 0.9 1 1.7 0.5 0.5 0 1.5 0 0 0 0 0 0.7 2.4 1.1 1.7
chr6:45553288 7.5 7.1 4.6 8.1 7.6 5.1 0.5 0 0 0.5 0.5 1.4 2.1 0.6 1.5 3.9 0 0 0 0 0 0.8 1 4.5 3.3 4.3 1.2
chr6:503851 7 5.6 1.4 8.1 5.4 6.5 1 0 0 0 0 5.2 3.1 3.5 3.4 1.5 0 0 0 0 0 2.3 1 3.7 3.3 2.1 1.2
chr9:16804167 76.5 80.3 69 74.2 75 66.4 0 0 0 0 0 22.6 26 13.4 12.1 14.1 0 1.5 0 0 0 9.8 8.9 29.1 48.6 46.3 12.2
chr9:16904635 19.3 22.7 17.6 17.7 19 17.8 0 0 0 0 0 4.7 6.2 5.2 2.9 4.9 0 0.5 0 0 0 3.8 3.6 9 12.9 9.6 4.1
chr10:70019371 15.9 12.6 13.4 23.7 15.2 15.9 16.5 12 16.7 15.7 10.4 22.6 22.4 27.9 22.8 18.9 0 0 0.9 0 0 3 6.2 23.9 11 21.8 48.8
chr10:94711457 1.7 2 1.9 1 2.2 2.8 0 0 0 0 0 0.9 0.5 2.9 0.5 1.5 0 0 0 0 0 0.8 0.5 2.2 0 2.7 2.3
chr11:89996325 4.1 3.5 1.9 6.1 4.3 2.8 1.5 1.4 1.4 0.5 0.5 4.7 5.7 3.5 3.4 1.5 0 0 0 0 0 0.8 0.5 0.7 3.3 2.1 2.9
chr14:92793206 8.9 12.1 14.8 5.6 8.7 10.7 3.9 4.3 4.2 5.6 4 3.3 6.2 2.9 3.9 4.9 0 0 0.4 0 0 0.8 2.1 9 14.8 8 5.2
chr15:84716986 26.6 28.8 30.1 27.8 24.5 24.8 6.3 2.4 6.5 5.6 6.9 16 25 19.8 17.5 21.8 0 1.5 0.4 0 0 4.5 3.1 16.4 21.4 17.6 15.1
chr16:89947203 9.7 6.6 6 5.6 11.4 5.1 20.4 10.6 32.9 42.9 39.6 2.8 3.6 2.3 0 0.5 0 0 0 0 0 2.3 2.1 5.2 2.9 1.1 1.2
chr19:31033240 16.2 18.7 13 19.7 15.8 17.8 0 0 0 0 0 4.2 1 1.2 6.8 2.4 0 0 0.4 0 0 3.8 2.1 7.5 12.9 12.8 5.2
